Literature DB >> 19779867

Role of adipocytokines in predicting the development of diabetes and its late complications.

Nese Ersoz Gulcelik1, Aydan Usman, Alper Gürlek.   

Abstract

Diabetes is an important health problem since the incidence of diabetes is continuously increasing. Early diagnosis is important as type 2 diabetes begins long before we diagnose it, leading to a complicated course of the disease. In order to prevent delay in the diagnosis of type 2 diabetes, novel predictors and pathways for type 2 diabetes are mounting. Diabetic complications are common cause of morbidity and mortality among subjects with diabetes. In the pathogenesis of diabetic complications some factors other than chronic hyperglycemia may be involved. Adipocytokines play important roles in the pathogenesis of diabetes mellitus, insulin resistance, and associated metabolic conditions such as hypertension and dyslipidemia. The investigations on the role of adipocytokines in developing diabetes and its complications have been made. In this review, we discussed the implications of adipocytokines in predicting diabetes and diabetic complications, with particular attention on the roles of adiponectin, leptin, visfatin, and vaspin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779867     DOI: 10.1007/s12020-009-9234-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  91 in total

1.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

2.  A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes.

Authors:  Yuan-Yuan Zhang; Lucia Gottardo; Ryan Thompson; Christine Powers; David Nolan; Jill Duffy; Maria Cristina Marescotti; Angelo Avogaro; Alessandro Doria
Journal:  Obesity (Silver Spring)       Date:  2006-12       Impact factor: 5.002

3.  Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

Authors:  J C Pickup; G D Chusney; S M Thomas; D Burt
Journal:  Life Sci       Date:  2000-06-08       Impact factor: 5.037

Review 4.  Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction.

Authors:  Jon G Mabley; Francisco Garcia Soriano
Journal:  Curr Vasc Pharmacol       Date:  2005-07       Impact factor: 2.719

5.  Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

Authors:  Joachim Spranger; Matthias Möhlig; Uta Wegewitz; Michael Ristow; Andreas F H Pfeiffer; Thilo Schill; Hans W Schlösser; Georg Brabant; Christof Schöfl
Journal:  Clin Endocrinol (Oxf)       Date:  2004-12       Impact factor: 3.478

6.  Adiponectin is an independent determinant of insulin resistance in women with polycystic ovary syndrome.

Authors:  Nese Ersoz Gulcelik; Yalcin Aral; Rustu Serter; Yavuz Demir; Cavit Culha
Journal:  Gynecol Endocrinol       Date:  2006-09       Impact factor: 2.260

7.  Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors.

Authors:  S Müller; S Martin; W Koenig; P Hanifi-Moghaddam; W Rathmann; B Haastert; G Giani; T Illig; B Thorand; H Kolb
Journal:  Diabetologia       Date:  2002-05-08       Impact factor: 10.122

8.  Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy.

Authors:  Jun Koshimura; Hiroki Fujita; Takuma Narita; Takashi Shimotomai; Mihoko Hosoba; Naomi Yoshioka; Masafumi Kakei; Hiromi Fujishima; Seiki Ito
Journal:  Biochem Biophys Res Commun       Date:  2004-03-26       Impact factor: 3.575

9.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  17 in total

1.  Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin.

Authors:  Ludovico Abenavoli; Natasa Milic; Francesco Capasso
Journal:  Endocrine       Date:  2012-12       Impact factor: 3.633

2.  The relationship of plasma adiponectin with liver fibrosis in morbid obesity.

Authors:  Teoman Dogru; Nuri Karadurmus; Guldem Kilciler; Serkan Tapan; Cemal Nuri Ercin
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

3.  Association of Type 2 Diabetes Mellitus related SNP genotypes with altered serum adipokine levels and metabolic syndrome phenotypes.

Authors:  Nasser M Al-Daghri; Omar S Al-Attas; Soundararajan Krishnaswamy; Abdul Khader Mohammed; Amal M Alenad; George P Chrousos; Majed S Alokail
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 4.  Vaspin in obesity and diabetes: pathophysiological and clinical significance.

Authors:  Matthias Blüher
Journal:  Endocrine       Date:  2011-12-03       Impact factor: 3.633

5.  Assessment of Serum VASPIN Levels among Type 2 Diabetes Mellitus Patients with or without Acute Coronary Syndrome.

Authors:  Aswathy Jaya Sathyaseelan; Prashant Shankarrao Adole; Mukta Wyawahare; Rama Prakasha Saya
Journal:  J Clin Diagn Res       Date:  2016-12-01

6.  Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus.

Authors:  Sema Uslu; Nur Kebapçi; Mehmet Kara; Cengiz Bal
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

Review 7.  Physiological and pathophysiological roles of NAMPT and NAD metabolism.

Authors:  Antje Garten; Susanne Schuster; Melanie Penke; Theresa Gorski; Tommaso de Giorgis; Wieland Kiess
Journal:  Nat Rev Endocrinol       Date:  2015-07-28       Impact factor: 43.330

8.  Resistance training decreases serum inflammatory markers in diabetic rats.

Authors:  Elahe Talebi-Garakani; Alireza Safarzade
Journal:  Endocrine       Date:  2012-09-05       Impact factor: 3.633

9.  The relationship between longitudinal serum leptin measures and measures of magnetic resonance imaging-assessed knee joint damage in a population of mid-life women.

Authors:  Carrie A Karvonen-Gutierrez; Siobán D Harlow; Jon Jacobson; Peter Mancuso; Yebin Jiang
Journal:  Ann Rheum Dis       Date:  2013-04-10       Impact factor: 19.103

10.  Taurine ameliorates hyperglycemia and dyslipidemia by reducing insulin resistance and leptin level in Otsuka Long-Evans Tokushima fatty (OLETF) rats with long-term diabetes.

Authors:  Kyoung Soo Kim; Da Hee Oh; Jung Yeon Kim; Bong Gn Lee; Jeong Soon You; Kyung Ja Chang; Hyun Ju Chung; Myung Chul Yoo; Hyung In Yang; Ja Heon Kang; Yoo Chul Hwang; Kue Jeong Ahn; Ho Yeon Chung; In Kyung Jeong
Journal:  Exp Mol Med       Date:  2012-11-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.